Chari highlights the importance of policy change as a key indicator of program success in combating discrimination related to hepatitis B. With a helpline documenting thousands of contacts each year, the data reflects shifting concerns, particularly a growing need for medication access. The potential for grassroots advocacy is immense, as mobilizing the voices of the 300 million affected individuals could lead to significant change in testing and treatment access.
